Butturini A, Sthivelman E, Canaani E, Gale R P
Department of Pediatrics, UCLA School of Medicine.
Acta Haematol. 1987;78 Suppl 1:2-10. doi: 10.1159/000205895.
Eukaryotic cells contain a family of genes termed cellular oncogenes or proto-oncogenes thought to regulate normal cell growth and development. In some abnormal circumstances, such as following transduction by retroviruses, activation of these genes causes tumors and leukemias in animals. Possible mechanisms of activation of cellular oncogenes include: (1) point mutation, deletion, insertion; (2) amplification; (3) activation by internal rearrangement, chromosomal translocation or promoter insertion, and (4) recombinatorial events resulting in the formation of novel chimeric genes, and others. In this review, we consider data implicating activation of cellular oncogenes in the pathogenesis of leukemia in man. We discuss possible mechanisms whereby oncogene activation may induce leukemias as well as the potential diagnostic and therapeutic implication.
真核细胞含有一类被称为细胞癌基因或原癌基因的基因家族,它们被认为可调节正常细胞的生长和发育。在某些异常情况下,如逆转录病毒转导后,这些基因的激活会导致动物发生肿瘤和白血病。细胞癌基因激活的可能机制包括:(1)点突变、缺失、插入;(2)扩增;(3)通过内部重排、染色体易位或启动子插入激活,以及(4)导致形成新的嵌合基因的重组事件等。在本综述中,我们考虑了有关细胞癌基因激活与人白血病发病机制相关的数据。我们讨论了癌基因激活可能诱导白血病的潜在机制以及潜在的诊断和治疗意义。